1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian CancerPlatinum-sensitive Recurrent Ovarian CancerNot yet recruitingPhase 32026-09-16NCT07821606